Thoma B, Bird T A, Friend D J, Gearing D P, Dower S K
Department of Biochemistry, Immunex Corporation, Seattle, Washington 98101.
J Biol Chem. 1994 Feb 25;269(8):6215-22.
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) both bind to the same receptor with high affinity and thus mediate an overlapping spectrum of biological activities, the signal transduction mechanisms for which are unclear. We show that mitogen-activated protein kinases are involved in both the LIF and OSM signal transduction pathways. However, we found that OSM is a much more potent inducer of both mitogen-activated protein kinase activity and biological response, both of which correlate with the expression of a second OSM receptor that does not bind LIF. In addition, different patterns of tyrosine-phosphorylated proteins were stimulated by OSM and LIF. We therefore suggest that the two receptors for OSM can be coupled to different signal transduction events.
白血病抑制因子(LIF)和抑瘤素M(OSM)均以高亲和力与同一受体结合,从而介导一系列重叠的生物学活性,但其信号转导机制尚不清楚。我们发现丝裂原活化蛋白激酶参与了LIF和OSM信号转导途径。然而,我们发现OSM是丝裂原活化蛋白激酶活性和生物学反应的更强诱导剂,二者均与不结合LIF的第二种OSM受体的表达相关。此外,OSM和LIF刺激产生不同模式的酪氨酸磷酸化蛋白。因此,我们认为OSM的两种受体可与不同的信号转导事件偶联。